168 related articles for article (PubMed ID: 30631005)
1. A four-methylated mRNA signature-based risk score system predicts survival in patients with hepatocellular carcinoma.
Wang Y; Ruan Z; Yu S; Tian T; Liang X; Jing L; Li W; Wang X; Xiang L; Claret FX; Nan K; Guo H
Aging (Albany NY); 2019 Jan; 11(1):160-173. PubMed ID: 30631005
[TBL] [Abstract][Full Text] [Related]
2. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
5. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
6. A novel DNA methylation-driver gene signature for long-term survival prediction of hepatitis-positive hepatocellular carcinoma patients.
Fu J; Qin W; Tong Q; Li Z; Shao Y; Liu Z; Liu C; Wang Z; Xu X
Cancer Med; 2022 Dec; 11(23):4721-4735. PubMed ID: 35637633
[TBL] [Abstract][Full Text] [Related]
7. A methylation-based mRNA signature predicts survival in patients with gastric cancer.
Li Y; Sun R; Zhang Y; Yuan Y; Miao Y
Cancer Cell Int; 2020; 20():284. PubMed ID: 32647495
[TBL] [Abstract][Full Text] [Related]
8. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
[TBL] [Abstract][Full Text] [Related]
9. Four differentially methylated gene pairs to predict the prognosis for early stage hepatocellular carcinoma patients.
Liu S; Miao C; Liu J; Wang CC; Lu XJ
J Cell Physiol; 2018 Sep; 233(9):6583-6590. PubMed ID: 29115664
[TBL] [Abstract][Full Text] [Related]
10. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma.
Cho CS; Gonen M; Shia J; Kattan MW; Klimstra DS; Jarnagin WR; D'Angelica MI; Blumgart LH; DeMatteo RP
J Am Coll Surg; 2008 Feb; 206(2):281-91. PubMed ID: 18222381
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Sang L; Wang XM; Xu DY; Zhao WJ
World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
[TBL] [Abstract][Full Text] [Related]
12. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
[TBL] [Abstract][Full Text] [Related]
13. A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction.
Wang Z; Teng D; Li Y; Hu Z; Liu L; Zheng H
Life Sci; 2018 Jun; 203():83-91. PubMed ID: 29678742
[TBL] [Abstract][Full Text] [Related]
14. A three-long non-coding RNA-expression-based risk score system can better predict both overall and recurrence-free survival in patients with small hepatocellular carcinoma.
Gu J; Zhang X; Miao R; Ma X; Xiang X; Fu Y; Liu C; Niu W; Qu K
Aging (Albany NY); 2018 Jul; 10(7):1627-1639. PubMed ID: 30018179
[TBL] [Abstract][Full Text] [Related]
15. Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.
Wu HY; Peng ZG; He RQ; Luo B; Ma J; Hu XH; Dang YW; Chen G; Pan SL
Int J Oncol; 2019 Aug; 55(2):425-438. PubMed ID: 31268164
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
[TBL] [Abstract][Full Text] [Related]
17. Mining featured biomarkers associated with vascular invasion in HCC by bioinformatics analysis with TCGA RNA sequencing data.
Zhang R; Ye J; Huang H; Du X
Biomed Pharmacother; 2019 Oct; 118():109274. PubMed ID: 31545220
[TBL] [Abstract][Full Text] [Related]
18. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of mRNA expression of phospholipase C β family genes in hepatitis B virus‑associated hepatocellular carcinoma.
Wang X; Huang K; Zeng X; Liu Z; Liao X; Yang C; Yu T; Han C; Zhu G; Qin W; Peng T
Oncol Rep; 2019 May; 41(5):2855-2875. PubMed ID: 30896816
[TBL] [Abstract][Full Text] [Related]
20. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
